University of Ioannina
Πρόληψη της έκτοπης οστεοποίησης μετά από ολική αρθροπλαστική του ισχίου
Abstract
dc:descriptionNon-steroidal anti-inflammatory drugs (NSAIDs) and radiotherapy are the two main therapeutic options for the prevention of heterotopic ossification (HO) in high risk patients that undergo total hip arthroplasty (THA). Given that the mechanism of action of these two therapeutic options is different, the aim of the current thesis is to investigate the efficacy of combined indomethacin of 75mg for 15 days postoperatively and postoperative radiotherapy in the prevention of HO after THA. Between 1992 and 2006, 271 high risk patients received therapy for the prevention of HO after THA at the University Hospital of Ioannina. The study was divided in 2 retrospective parts and 1 prospective part. In the first retrospective part we aimed to investigate the efficacy of postoperative fractionated radiotherapy of 10.0 Gy compared to a single dose of 7.0 Gy in combination with indomethacin (75 mg for 15 days). In the second retrospective part of the thesis we evaluated the efficacy of the combined therapeutic protocol and we tried to identify risk factors associated with HO development. In the third prospective part of the thesis, we evaluated the efficacy of the combined protocol compared to indomethacin alone and we tried to identify new risk factors associated with increased incidence of HO after THA. Finally, we evaluated the efficacy of the combined protocol in a subgroup of patients with congenital hip disease (CDH). All patients were evaluated radiologically with the Brooker classification and clinically with the Merle d’Aubigne score. In the first retrospective part of this thesis 71 patients were included and no radiological difference in the development of HO was observed between the group of fractionated dose of radiotherapy and the group of the single dose. The overall incidence of HO was 7%. In the second retrospective part of the thesis the overall incidence was approximately 20%, while patients with CDH had increased possibility for HO development compared to patients with osteoarthritis of the hip. In the third prospective part of the thesis the incidence of HO development was approximately 20%. Patients that received the combined therapeutic protocol had lower incidence of HO development compared to patients that received indomethacin alone. Patients with CDH had increased risk for HO development. The overall incidence of HO in patients with CDH was approximately 31%. In these patients the combined protocol was also more effective than indomethacin alone, although the difference was not statistically significant. In all the three parts of the thesis no significant treatment related side effects were observed.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pakos, Emilios
- Πάκος, Αιμίλιος
Subjects
dc:subject × 20- Ολική αρθροπλαστική ισχίου
- Έκτοπη οστεοποίηση
- Πρόληψη
- Ινδομεθακίνη
- Ακτινοθεραπεία
- Συνδυασμένη θεραπεία
- Υπερτροφική οστεοαρθρίτιδα
- Συγγενές εξάρθρημα ισχίου
- Total hip arthroplasty
- Heterotopic ossification
- Prevention
- Indomethacin
- Radiotherapy
- Combined treatment
- Hypertrophic osteoarthritis
- Congenital hip disease
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18625